Patents by Inventor Ching-Li Tseng

Ching-Li Tseng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SELF-ASSEMBLED NANOPARTICLE AND USE THEREOF FOR ANTI- ANGIOGENESIS
    Publication number: 20240033316
    Abstract: Provided is a nanoparticle or a pharmaceutical composition including the same for treating or remitting a neovascularization or an angiogenesis in eye segments, and the nanoparticle includes a hyaluronic acid and a therapeutic peptide.
    Type: Application
    Filed: July 26, 2022
    Publication date: February 1, 2024
    Inventors: CHING-LI TSENG, YU-WEN CHENG, YU-YI WU, ERH-HSUAN HSIEH, JIA-HUA LIANG, FAN-LI LIN
  • Lutein-containing ophthalmic composition
    Patent number: 11426346
    Abstract: A lutein-containing ophthalmic composition, wherein the ophthalmic composition is mainly consisting of a natural anti-inflammatory substance, a substance with increasing liquid viscosity, and an artificial tear. The substance with increasing liquid viscosity could apply the ophthalmic composition to elongate the retention time on the ocular surface, thereby increasing the retention time of anti-inflammatory substance on the ocular surface for treating dry eye syndrome and inhibiting ocular surface inflammation.
    Type: Grant
    Filed: October 13, 2019
    Date of Patent: August 30, 2022
    Assignee: TAIPEI MEDICAL UNIVERSITY
    Inventors: Ching-Li Tseng, I-Chan Lin, Yi-Zhou Chen, Yu-Lun Chuang, Cheng-Han Tsai, Zhi-Yu Chen
  • LUTEIN-CONTAINING OPHTHALMIC COMPOSITION
    Publication number: 20200222316
    Abstract: A lutein-containing ophthalmic composition, wherein the ophthalmic composition is mainly consisting of a natural anti-inflammatory substance, a substance with increasing liquid viscosity, and an artificial tear. The substance with increasing liquid viscosity could apply the ophthalmic composition to elongate the retention time on the ocular surface, thereby increasing the retention time of anti-inflammatory substance on the ocular surface for treating dry eye syndrome and inhibiting ocular surface inflammation.
    Type: Application
    Filed: October 13, 2019
    Publication date: July 16, 2020
    Inventors: CHING-LI TSENG, I-CHAN LIN, YI-ZHOU CHEN, YU-LUN CHUANG, CHENG-HAN TSAI, ZHI-YU CHEN
  • Artificial tears solution combination
    Patent number: 9782385
    Abstract: An artificial tears solution combination is composed mainly of an anti-inflammation and anti-oxidation material, a liquid viscosity-enhancing agent, and an artificial tears solution. The artificial tears solution combination is capable keeping moisture, and meanwhile having anti-inflammation and anti-oxidation capabilities. As such, it can prolong the liquid retention on ocular surfaces, to effective reduce the repeated dosing, and shorten the schedule for the dry eye syndrome.
    Type: Grant
    Filed: April 29, 2016
    Date of Patent: October 10, 2017
    Assignee: NATIONAL HEALTH RESEARCH INSTITUTES
    Inventors: Feng-Huei Lin, Hsu-Wei Fang, Ching-Li Tseng, Ya-Jung Hung
  • Artificial Tears Solution Combination
    Publication number: 20160317491
    Abstract: An artificial tears solution combination is composed mainly of an anti-inflammation and anti-oxidation material, a liquid viscosity-enhancing agent, and an artificial tears solution. The artificial tears solution combination is capable keeping moisture, and meanwhile having anti-inflammation and anti-oxidation capabilities. As such, it can prolong the liquid retention on ocular surfaces, to effective reduce the repeated dosing, and shorten the schedule for the dry eye syndrome.
    Type: Application
    Filed: April 29, 2016
    Publication date: November 3, 2016
    Inventors: Feng-Huei Lin, Hsu-Wei Fang, Ching-Li Tseng, Ya-Jung Hung
  • PHARMACEUTICAL COMPOSITION FOR INHALATION DELIVERY AND FABRICATION METHOD THEREOF
    Publication number: 20100209519
    Abstract: A pharmaceutical composition for inhalation delivery is provided, including drugs and a gelatin nanoparticle encapsulating the drugs to form a drug-gelatin nanocomplex, wherein the surface of the gelatin nanoparticle is modified with cell-targeting molecules. A method for fabricating the pharmaceutical composition for inhalation delivery is also provided.
    Type: Application
    Filed: June 8, 2009
    Publication date: August 19, 2010
    Applicant: NATIONAL TAIWAN UNIVERSITY
    Inventors: Feng-Huei LIN, King-Jen CHANG, Ching-Li TSENG, Chung-Hung CHENG
  • Method for manufacturing DP-bioglass composition for use in dental fracture repair
    Patent number: 7569105
    Abstract: A method for manufacturing the DP-bioglass to use in dental fracture repair via the carbon dioxide laser, the method comprises the steps: mixing and co-dissolving silicon and phosphoric acid raw material into ethanol; sequentially adding nitric acid, calcium and sodium raw material and stirring; standing, drying, triturating and heating the composition to obtain a glass powder material consisting of Na2O—CaO—SiO2—P2O5 and drying the oxide material mixing with a phosphoric acid to react the DP-bioglass.
    Type: Grant
    Filed: November 7, 2005
    Date of Patent: August 4, 2009
    Assignee: National Taiwan University
    Inventors: Feng Huei Lin, Chun-Pin Lin, Ching-Li Tseng